OverviewWhy MagtraceReviews
Evaluate Magtrace®
Magtrace®

A simple solution for breast cancer staging

Iron oxide. Sugar. Salt. Water. Four simple ingredients that together provide a safe and flexible way to stage early breast cancer.

Particles optimised for nodes

The tiny particles are optimised for migration and uptake in the lymph nodes, providing a clear signal as well as visual guidance when performing sentinel node biopsy procedures.

Everything you need. Any time you need it.

Magtrace® is a single injection, dual-tracer that works in minutes. It remains in the sentinel lymph nodes for at least a month, so you can plan injections to suit you and your patient.

Put patient comfort first

Eliminate patient pain by injecting Magtrace® in the OR after anaesthesia. If injected days before surgery, Magtrace can cause less discomfort than radioactive isotopes.

No benefit? No surgery. No brainer.

The 30-day injection window means that some DCIS patients could avoid unnecessary lymph node surgery, as surgery only needs to proceed after pathology has confirmed there is a benefit in doing so.

Particles optimised for nodes

The tiny particles are optimised for migration and uptake in the lymph nodes, providing a clear signal as well as visual guidance when performing sentinel node biopsy procedures.

Everything you need. Any time you need it.

Magtrace® is a single injection, dual-tracer that works in minutes. It remains in the sentinel lymph nodes for at least a month, so you can plan injections to suit you and your patient.

Put patient comfort first

Eliminate patient pain by injecting Magtrace® in the OR after anaesthesia. If injected days before surgery, Magtrace can cause less discomfort than radioactive isotopes.

No benefit? No surgery. No brainer.

The 30-day injection window means that some DCIS patients could avoid unnecessary lymph node surgery, as surgery only needs to proceed after pathology has confirmed there is a benefit in doing so.

Why magnetic tracers?

Magnetic tracers have been designed to simplify breast cancer staging, to make it more convenient and more widely available, without compromising on clinical effectiveness.

  • Accurate

    Clinical trials have shown Magtrace® to be non-inferior to the combination of radioisotope +/- blue dyes.

  • Safe

    No reported allergic reactions or anaphylaxis in over 100,000 cases.

  • Flexible

    Inject up to days or weeks prior to surgery without compromising the efficacy or accuracy.

  • Radiation-free

    Iron oxide. Sugar. Salt. Water. A simple solution to replace radioactive tracers.

Trusted by experts, demanded by patients

Hear how world-leading physicians are enjoying the truly unique benefits of the Magtrace® lymphatic tracer to provide a more flexible approach to SLNB and avoid surgery when it’s not needed.

Dr. Ashley Simpson
Dr. Anne Peled
Dr. Janette Gomez
Dr. Patricia Clark & Dr. Cindy Mac
Dr. Ashley Simpson
Dr. Anne Peled
Dr. Janette Gomez
Dr. Patricia Clark & Dr. Cindy Mac
Magtrace is a real game-changer to the way we treat breast cancer in the United States.
Dr. Laura Esserman UCSF Breast Care Center
It's life changing for the patient and practice changing for us. It does a great job.
Dr. Lucy De La Cruz MedStar Georgetown University Hospital
Given enough time and dispersement of this information and technology, Delayed Sentinel Node Biopsy will become a standard.
Dr. Shawna Willey Inova Schar Cancer Institute
This is the one product I've seen that provides a real benefit to the patient that is substantial.
Dr. Janette Gomez Allegheny General Hospital
Magtrace is a real game-changer to the way we treat breast cancer in the United States.
Dr. Laura Esserman UCSF Breast Care Center
It's life changing for the patient and practice changing for us. It does a great job.
Dr. Lucy De La Cruz MedStar Georgetown University Hospital
Given enough time and dispersement of this information and technology, Delayed Sentinel Node Biopsy will become a standard.
Dr. Shawna Willey Inova Schar Cancer Institute
This is the one product I've seen that provides a real benefit to the patient that is substantial.
Dr. Janette Gomez Allegheny General Hospital
Magtrace Collaboration
Dr. Kristalyn Gallagher
Holly Miller & Dr. Shawna Willey
Dr. Kelly Hewitt
Magtrace Collaboration
Dr. Kristalyn Gallagher
Holly Miller & Dr. Shawna Willey
Dr. Kelly Hewitt

Backed by data

185,000+

total patients treated

98.2%

sentinel lymph node detection rate

96.4%

nodal malignancy detection per patient

95.5%

nodal detection rate

2.3

average nodes obtained per patient

Clinical data

Related products

Sentimag®

Localisation and staging, together in one platform

Magseed®

Meet the seed that changed the game

Resources

Downloads

Download product and technique brochures for the Magtrace® lymphatic tracer.

FAQs

View frequently asked questions about the Magtrace® lymphatic tracer.

Clinical data: tracers

Read the latest Magtrace® data, including the groundbreaking SentiNOT study

Get started with your Magtrace® trial

Give your patients a better standard of breast cancer surgery without the need for radioactivity. Set up a Magtrace® lymphatic tracer evaluation today.

  • Evaluate Magtrace®
  • 185,000+ patients already treated
Arrange your Magtrace trial